3,3',4,5'-tetrahydroxystilbene has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tao, ZZ; Xu, B | 1 |
Jeong, JH; Kim, WY; Kim, Y; Lee, H; Ryu, JH | 1 |
2 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-Associated Death Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Humans; Inhibitory Concentration 50; Lung Neoplasms; Stilbenes; Up-Regulation | 2014 |
ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.
Topics: Antineoplastic Agents, Phytogenic; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Checkpoint Kinase 2; Humans; Lung Neoplasms; Proteome; Respiratory Mucosa; Resveratrol; Rheum; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53 | 2016 |